BlackRock, Inc.

BLK
About the company

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and...

Country: United StatesPrice: $1222.91Market Cap: $188.8B

Investment snapshot

29%positive consensus
Scored 1d ago

Positive

5

BUY / PASS

Neutral / negative

3 / 8

NEUTRAL / FAIL

Median fair value

$550.66

-55.0% vs price

Models with upside

0 / 17

Positive margin of safety

Strongest signal

8 of 12 pass — Graham, Dreman, Asness +1 more object

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILPASSNEUTRALNot rankedPASSFAILPASSFAILFAILFAILPASSFAILPASSNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/A
Margin of Safety-127.6%-178.6%-2568.4%-242.0%N/A-114.9%-122.1%-299.6%-22.6%-120.6%-47.9%-120.6%N/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-25

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-25

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-25

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-25

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-25

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage67% pass✓ 11✗ 4▾

    8 of 12 pass — Graham, Dreman, Asness +1 more object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.22, IC: 17.1x
    ✓BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.22
    ✓Lynch< 0.33
    Cash - Long-term Debt$137.0M
    ✓LynchPositive preferred
    LT Debt / Total Assets Change8.88% -> 7.51%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.22
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.22
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=14.6x, D/EBITDA=1.7x
    ✓MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.22
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.2192; #1751/4210 (top 41.6%)
    ✗AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✓ 9✗ 26▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)4/5 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)4/5 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)12.7%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)29.1% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$5.6B
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)26.68
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR1.3%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE11.9%
    ✗Lynch> 15%
    EBIT / Enterprise Value3.7%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=3.7%, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets3.27%
    ✓PiotroskiROA > 0
    ROA Change YoY4.59% -> 3.27% (delta: -1.33%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=2.31%, ROA=3.27%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue34.4%
    ✓Dreman>= 8%
    Net Income / Shareholders' Equity11.9%
    ✗Dreman> 12%
    Margin of SafetyP/E=34.6x, P/B=3.4x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity12.4% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value-114.9% (IV=$569.15 vs Price=$1222.91)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency4/4 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue32.5%
    ✓Ackman>= 15%
    Net Income / Shareholders Equity11.9%
    ✗Ackman>= 15%
    5-Year EPS CAGR1.3% CAGR over 3 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend57.0% (2023) -> 29.1% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 57.0% -> 29.1%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+3.66%; #2152/6340 (top 33.9%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+11.89%; #1533/5226 (top 29.3%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0060; #553/5884 (top 9.4%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR1.3% over 3 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation0% pass✓ 1✗ 27▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS32.2x
    ✗Graham<= 15x
    Price-to-Book Ratio3.4x
    ✗Graham<= 1.5x
    P/E x P/B108.50
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)26.68
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value3.7%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=3.7%, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS34.6x
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)47.9x
    ✗Dreman< 8x
    Price / Book Value per Share3.4x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=34.6x, OE Yield=2.9%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=34.6x, FCF Yield=1.9%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=34.6x, P/B=3.4x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value-114.9% (IV=$569.15 vs Price=$1222.91)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share53.0x
    ✗Ackman<= 25
    Price vs. Trailing Low134% of trailing low ($914.26)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+3.66%; #2152/6340 (top 33.9%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.3078; #3667/6449 (top 56.9%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS34.6x
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+46.2%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.1511; #4047/5247 (top 77.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+2.53%; #2145/4519 (top 47.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+22.38%; #1245/6202 (top 20.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Valuation models0% pass✗ 11▾

    BLK overvalued: all 11 models price fair value below $1222.91 (median $550.66)

    Graham fair value$537.20
    ✗Graham-127.6% margin vs $1222.91
    Buffett fair value$438.94
    ✗Buffett-178.6% margin vs $1222.91
    Lynch fair value$45.83
    ✗Lynch-2568.4% margin vs $1222.91
    Greenblatt fair value$357.60
    ✗Greenblatt-242.0% margin vs $1222.91
    Dreman fair value$569.15
    ✗Dreman-114.9% margin vs $1222.91
    Munger fair value$550.66
    ✗Munger-122.1% margin vs $1222.91
    Pabrai fair value$306.05
    ✗Pabrai-299.6% margin vs $1222.91
    Akre fair value$997.23
    ✗Akre-22.6% margin vs $1222.91
    Marks fair value$554.25
    ✗Marks-120.6% margin vs $1222.91
    Ackman fair value$827.03
    ✗Ackman-47.9% margin vs $1222.91
    Templeton fair value$554.25
    ✗Templeton-120.6% margin vs $1222.91
  • Efficiency13% pass✓ 3✗ 8▾

    7 of 8 flag BLK's efficiency — Graham, Greenblatt, Piotroski +4 more

    Current Ratio
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)11.8%
    ✓Buffett> 10%
    ROIC - WACC+1.8%
    ✓BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)
    ✗Greenblatt> 25%
    Current Ratio Change YoY
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.09x -> 0.14x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities
    ✗Dreman> 1.5
    Return on Invested Capital10.3%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=10.5%; FY2024: ROIC=10.0%; FY2025: ROIC=8.1%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC8.1% (RR=100% x ROIC=8.1%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/3 years above 12% (latest 8.1%)
    ✗SleepROIC > 12% in a majority of years
  • Growth25% pass✓ 6✗ 7▾

    6 of 8 flag BLK's growth — Graham, Lynch, Dreman +3 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)26.68
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR1.3%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$33.97 (2022) -> $35.31 (2025)
    ✓DremanPositive over recent years
    EPS CAGR1.3% CAGR over 3 years
    ✗Dreman> 5% annualized
    Positive Net Income Frequency4/4 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth16.2%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency2/3 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR1.3% CAGR over 3 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 57.0% -> 29.1%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR1.3% over 3 years
    ✗Neff7%-20% annualized
  • Verdicts38% pass✓ 5✗ 8▾

    Split decision: 8 FAIL · 5 PASS · 3 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (1/9)✓BuffettPASS (4/9)•LynchNEUTRAL (5/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 5)✗DremanFAIL (4/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (3/5)✓AckmanPASS (4/9)✗TempletonFAIL (3/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)
  • Cash Flow50% pass✓ 6✗ 6▾

    5 of 10 pass — Piotroski, Dreman, Pabrai +2 more object

    Free Cash Flow Proxy$5.6B
    ✓BuffettPositive and growing
    FCF Positive and Growing$4.8B
    ✓LynchPositive and growing
    Operating Cash Flow$3.9B
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=2.31%, ROA=3.27%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)47.9x
    ✗Dreman< 8x
    P/E or FCF YieldP/E=34.6x, FCF Yield=1.9%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive4/4 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap2.5%
    ✗Ackman>= 4%
    Price / FCF per Share53.0x
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency4/4 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$4.8B
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+2.53%; #2145/4519 (top 47.5%)
    ✗OshaughnessyTop 10% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Trading
SIC Sector: Security & Commodity Brokers
Size: Large Cap($188.8B)
Revenue: $24.2B+89.3% YoY
Net Income: $5.6B-12.8% YoY

Financial Snapshot

Operating Margin29.1%
Return on Equity9.9%
Debt / Equity0.23
Current Ratio--
EPS (Diluted)$35.31−15.9% 1y
Shares Retired0.7% / −3.6% 2y

Shareholder Return

Fiscal 2025

Retired 0.7% of shares last year, 3.6% issued over two.

Buybacks
—
Dividends
—

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY23
7.5% = 6.3% + 1.1%
FY24
15.1% = 15.8% + −0.6%
FY25
−15.9% = −12.8% + −3.6%
Earnings Fewer shares More shares

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, interest expense, operating cash flow, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-02-25
FY 2024
Sources
  • 10-K · 2025-02-25
FY 2023
Sources
  • 10-K · 2025-02-25
FY 2022
Sources
  • 10-K · 2025-02-25
FY 2021
Sources
  • 10-K · 2025-02-25
Market Cap$188.8Bcurrent------$171.2Best.$162.4Best.$109.4Best.$107.1Best.--
Revenue$28.5B↑25%$7.8B↑19%$7.1B↑31%$6.7B↑27%$24.2B↑89%$12.8B↑16%$11.0B$11.1B--
Operating Income$9.3B↑24%$2.3B↑19%$2.5B↑42%$2.8B↑66%$7.0B↓7%$7.6B↑21%$6.3B↓2%$6.4B--
Net Income$6.9B↑13%$1.7B↑25%$1.9B↑20%$2.2B↑46%$5.6B↓13%$6.4B↑16%$5.5B↑6%$5.2B--
EPS (Diluted)--$10.57↑25%$12.19↑20%$14.06↑46%$35.31↓16%$42.01↑15%$36.51↑7%$33.97--
Gross Margin—————————
Operating Margin32.5%30.0%34.7%↑9%42.0%↑31%29.1%↓51%59.2%↑4%57.0%↓1%57.7%—
ROE11.9%↑8%———9.9%↓26%13.4%↓4%14.0%↑2%13.7%—
Total Debt$12.7B$12.7B$12.7B$12.7B↑3%$12.8B↑4%$12.3B↑56%$7.9B----
Shareholders' Equity$58.1B↑5%$58.1B↑5%$57.6B↑17%$56.7B↑18%$55.9B↑18%$47.5B↑21%$39.3B↑4%$37.9B$37.8B
Current Ratio—————————
Debt / Equity0.22↓5%0.22↓5%0.22↓15%0.22↓13%0.23↓12%0.26↑29%0.20——
Operating Cash Flow$5.2B↑23%$2.7B↑91%$1.2B↓10%-$980.0M↑13%$3.9B↓21%$5.0B↑19%$4.2B↓16%$5.0B--
Free Cash Flow$4.8B↑22%$2.6B↑95%$1.1B↓12%-$1.1B↑10%$3.6B↓24%$4.7B↑23%$3.8B↓14%$4.4B--

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Trading

BLK vs Peers — Financial Grading

Revenue$24.2BTop 25%
Net Income$5.6BTop 25%
ROE9.9%Top 25%
D/E0.23Top 25%
Op. Margin29.1%Median
Curr. Ratio—
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
REALTY INCOME CORPO$56.1B$58.82$5.7B$1.1B2.7%0.6316.8%—2/71/93/70/3F-Score 64/10
Ventas, Inc.VTR$47.0B$88.92$5.8B$261.5M2.1%1.043.5%—2/71/92/70/3F-Score 62/10
RAYMOND JAMES FINANCIAL INCRJF$32.4B$168.64$15.9B$2.1B17.1%0.28——3/93/93/71/3F-Score 64/11
ROYAL GOLD INCRGLD$21.7B$256.89$1.0B$466.3M6.5%0.1361.9%3.124/92/94/70/3F-Score 44/11
iShares Ethereum Trust ETFETHA$19.4B$44.02—$2.3B——————————
KIMCO REALTY CORPKIM$17.0B$25.55$2.1B$584.7M5.6%0.7436.0%—3/72/94/70/3F-Score 75/10
LandBridge Co LLCLB$5.6B$73.15$199.1M$30.1M8.9%1.6559.5%4.872/93/92/70/3F-Score 63/11
Digital Turbine, Inc.APPS$927.6M$7.61$565.3M$37.7M-19.6%1.886.0%1.161/92/92/71/3F-Score 70/11